Clinicopathologic and Survival Differences between Upper and Lower Extremity Melanomas

This analysis was performed to compare differences in clinicopathologic factors, sentinel lymph node (SLN) status, and survival between upper extremity (UE) and lower extremity (LE) melanoma patients. Post hoc analysis of a prospective clinical trial was performed of all patients with extremity melanomas with complete data. Survival was evaluated with Kaplan-Meier analysis. Univariate and multivariate analyses were performed. A total of 1115 patients aged 18 to 70 years with extremity melanomas ≥ 1.0 mm Breslow thickness were analyzed; all underwent SLN biopsy with completion lymphadenectomy for a tumor-positive SLN. Compared with UE patients, LE melanoma patients were younger, predominantly female, and had a higher rate of SLN metastasis. Kaplan-Meier analysis revealed worse 5-year disease-free survival (DFS) and worse local and in-transit recurrence-free survival in LE versus UE melanoma patients, but no difference in overall survival (OS). Subgroup analysis revealed that older patients (age > 51 years) with LE melanomas had worse DFS, local and in-transit recurrence-free-survival, and OS. LE tumor location was not an independent risk factor for OS or DFS. Compared with UE melanoma patients, those with LE melanomas have a greater risk of tumor-positive SLN and local/in-transit recurrence.

[1]  A. Halpern,et al.  A Prognostic Model for Predicting 10-Year Survival in Patients with Primary Melanoma , 1996, Annals of Internal Medicine.

[2]  Jeffrey E. Lee,et al.  Significance of Multiple Nodal Basin Drainage in Truncal Melanoma Patients Undergoing Sentinel Lymph Node Biopsy , 2000, Annals of Surgical Oncology.

[3]  R. Elashoff,et al.  Individualized prognosis for melanoma patients. , 2000, Human pathology.

[4]  P. Gimotty,et al.  Predicting Survival Outcome of Localized Melanoma: An Electronic Prediction Tool Based on the AJCC Melanoma Database , 2010, Annals of Surgical Oncology.

[5]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Jeffrey E. Lee,et al.  Revised American Joint Committee on Cancer Staging Criteria Accurately Predict Sentinel Lymph Node Positivity in Clinically Node-Negative Melanoma Patients , 2003, Annals of Surgical Oncology.

[7]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[8]  J. Bulliard.  Site‐specific risk of cutaneous malignant melanoma and pattern of Sun exposure in New Zealand , 2000, International journal of cancer.

[9]  A. Hauschild,et al.  Factors Predictive of the Status of Sentinel Lymph Nodes in Melanoma Patients from a Large Multicenter Database , 2011, Annals of Surgical Oncology.

[10]  Ajay N. Jain,et al.  Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.

[11]  J. Shah,et al.  Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma , 2010, Head & neck.

[12]  R. Scolyer,et al.  Factors Predicting Recurrence and Survival in Sentinel Lymph Node-Positive Melanoma Patients , 2011, Annals of surgery.

[13]  M. Ross,et al.  Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  Yan Xing,et al.  Conditional survival estimates improve over time for patients with advanced melanoma , 2010, Cancer.

[15]  Grant W. Carlson,et al.  Regional Recurrence After Negative Sentinel Lymph Node Biopsy for Melanoma , 2008, Annals of surgery.

[16]  A. Stromberg,et al.  Correlation Between Prognostic Factors and Increasing Age in Melanoma , 2004, Annals of Surgical Oncology.

[17]  C. Corless,et al.  Sentinel node staging of primary melanoma by the "10% rule": pathology and clinical outcomes. , 2007, American journal of surgery.

[18]  M. Ross,et al.  Final results of the Sunbelt Melanoma Trial , 2008 .

[19]  M. Ross,et al.  Lessons learned from the Sunbelt Melanoma Trial , 2004, Journal of surgical oncology.

[20]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Y. Hemo,et al.  Anatomic site of primary melanoma is associated with depth of invasion. , 1999, Archives of surgery.

[22]  R. Gallagher,et al.  Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.

[23]  Michael E. Egger,et al.  Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. , 2011, American journal of surgery.

[24]  B. Armstrong,et al.  Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. , 1986, Journal of the National Cancer Institute.

[25]  Gary Lyman,et al.  Age as a prognostic factor in the malignant melanoma population , 1994, Annals of Surgical Oncology.

[26]  C. Garbe,et al.  Primary cutaneous melanoma. Prognostic classification of anatomic location , 1995, Cancer.

[27]  S. Ariyan,et al.  Gender-Related Differences in Outcome for Melanoma Patients , 2006, Annals of surgery.

[28]  V. Sondak,et al.  The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma , 2007, Cancer.

[29]  Jeffrey E Gershenwald,et al.  Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  C. Garbe,et al.  Age and gender are significant independent predictors of survival in primary cutaneous melanoma , 2008, Cancer.

[31]  M. Ross,et al.  Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. , 2001, Surgery.

[32]  C. Corless,et al.  Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes. , 2010, American journal of surgery.

[33]  S. Leong,et al.  Prediction of sentinel lymph node micrometastasis by histological features in primary cutaneous malignant melanoma. , 1998, Archives of dermatology.